Farallon Capital Management, Millennium Management, Magnetar and Ziff Capital are among the growing number of hedge funds, private equity firms and mutual fund companies investing in private placement rounds with biotech startups in this week's Alts Watch Healthcare Beat.
We tracked a total of three deals involving $300 million in fresh capital in the shortened holiday week ending December 27. The focus ranged from clinical diagnostics, immunotherapies and the promise of "molecular" glue.
As always, here is our summary of who, what and why each company story is attracting attention.
Continue Reading
Not a subscriber yet? Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
